Association of Inflammatory Cytokines With Non-Alcoholic Fatty Liver Disease

NRF2 -617 C/A Polymorphism Impacts Proinflammatory Cytokine Levels, Survival, and Transplant-Related Mortality After Hematopoietic Stem Cell Transplantation in Adult Patients Receiving Busulfan-Based Conditioning Regimens

(2021) Jingjing Huang et al.   Frontiers in Pharmacology

Non-alcoholic fatty liver disease

(2021) Elizabeth E Powell et al.   LANCET

Role of the Inflammasome in Liver Disease

(2021) Marcelle de Carvalho Ribeiro et al.   Annual Review of Pathology-Mechanisms of Disease

PNPLA3, TM6SF2, and MBOAT7 Influence on Nutraceutical Therapy Response for Non-alcoholic Fatty Liver Disease: A Randomized Controlled Trial

(2021) Marcello Dallio et al.   Frontiers in Medicine

Development and Validation of a Scoring System, Based on Genetic and Clinical Factors, to Determine Risk of Steatohepatitis in Asian Patients with Nonalcoholic Fatty Liver Disease

(2020) Bo Kyung Koo et al.   Clinical Gastroenterology and Hepatology

NAFLD 2020: The State of the Disease

(2020) Thomas G. Cotter et al.   GASTROENTEROLOGY

Relationship between IL-8 Circulating Levels and TLR2 Hepatic Expression in Women with Morbid Obesity and Nonalcoholic Steatohepatitis

(2020) Teresa Auguet et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Heightened Plasma Levels of Transforming Growth Factor Beta (TGF-β) and Increased Degree of Systemic Biochemical Perturbation Characterizes Hepatic Steatosis in Overweight Pediatric Patients: A Cross-Sectional Study

(2020) Junaura R. Barretto et al.   Nutrients

Screening for nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus using transient elastography - a prospective, cross sectional study

(2020) I Mikolasevic et al.   European Journal of Internal Medicine

Association Between Leukocyte Mitochondrial DNA Copy Number and Non-alcoholic Fatty Liver Disease in a Chinese Population Is Mediated by 8-Oxo-2′-Deoxyguanosine

(2020) Chifa Ma et al.   Frontiers in Medicine

Myeloid cell‐specific IL‐6 signaling promotes miR‐223‐enriched exosome production to attenuate NAFLD‐associated fibrosis

(2020) Xin Hou et al.   HEPATOLOGY

Non-Alcoholic Steatohepatitis: A Review of Its Mechanism, Models and Medical Treatments

(2020) Cheng Peng et al.   Frontiers in Pharmacology

Serum fetuin-B level is an independent marker for nonalcoholic fatty liver disease in patients with type 2 diabetes

(2019) Hazem M. El-Ashmawy et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Potential Nexus of Non-alcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus: Insulin Resistance Between Hepatic and Peripheral Tissues

(2019) Wan Mu et al.   Frontiers in Pharmacology

CRP-Induced NLRP3 Inflammasome Activation Increases LDL Transcytosis Across Endothelial Cells

(2019) Fang Bian et al.   Frontiers in Pharmacology

Neutrophil-to-lymphocyte ratio is independently associated with inflammatory activity and fibrosis grade in nonalcoholic fatty liver disease

(2019) Tawfik Khoury et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Epigenetic Markers and Microbiota/Metabolite-Induced Epigenetic Modifications in the Pathogenesis of Obesity, Metabolic Syndrome, Type 2 Diabetes, and Non-alcoholic Fatty Liver Disease

(2019) Daniela Stols-Gonçalves et al.   Current Diabetes Reports

Laparoscopic sleeve gastrectomy reverses non-alcoholic fatty liver disease modulating oxidative stress and inflammation

(2019) Noemí Cabré et al.   METABOLISM-CLINICAL AND EXPERIMENTAL

Hepatocellular carcinoma is associated with gut microbiota profile and inflammation in nonalcoholic fatty liver disease

(2018) Francesca Romana Ponziani et al.   HEPATOLOGY

Circulating Interleukin-6 is a biomarker for coronary atherosclerosis in nonalcoholic fatty liver disease: Results from the Multi-Ethnic Study of Atherosclerosis

(2018) Tracey G. Simon et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Mechanisms of NAFLD development and therapeutic strategies

(2018) Scott L. Friedman et al.   NATURE MEDICINE

OUP accepted manuscript

(2018)   NUTRITION REVIEWS

Taurine attenuates arsenic-induced pyroptosis and nonalcoholic steatohepatitis by inhibiting the autophagic-inflammasomal pathway

(2018) Tianming Qiu et al.   Cell Death & Disease

Molecular pathways of nonalcoholic fatty liver disease development and progression

(2018) Fernando Bessone et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Modulation of Insulin Resistance in NAFLD

(2018) Reenam Khan et al.   HEPATOLOGY

The associations among Helicobacter pylori infection, white blood cell count and nonalcoholic fatty liver disease in a large Chinese population

(2018) Ying-ying Yu et al.   MEDICINE

Nonalcoholic Fatty Liver Disease

(2018) Irene Pierantonelli et al.   TRANSPLANTATION

Nonalcoholic fatty liver disease in chronic obstructive pulmonary disease

(2017) Damien Viglino et al.   EUROPEAN RESPIRATORY JOURNAL

Relationship between Oxidative Stress, Inflammation and Dyslipidemia with Fatty Liver Index in Patients with Type 2 Diabetes Mellitus

(2017) Aleksandra Klisic et al.   EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES

Do Genetic Markers of Inflammation Modify the Relationship between Periodontitis and Nonalcoholic Fatty Liver Disease? Findings from the SHIP Study

(2017) A.A. Akinkugbe et al.   JOURNAL OF DENTAL RESEARCH

Relationships of serum high-sensitivity C-reactive protein and body size with insulin resistance in a Japanese cohort

(2017) Hirokazu Uemura et al.   PLoS One

The Association of Inflammatory Markers With Nonalcoholic Fatty Liver Disease Differs by Human Immunodeficiency Virus Serostatus

(2017) Jennifer C Price et al.   Open Forum Infectious Diseases

High-normal levels of hs-CRP predict the development of non-alcoholic fatty liver in healthy men

(2017) Jieun Lee et al.   PLoS One

Innate Immunity and Inflammation in NAFLD/NASH

(2016) Marco Arrese et al.   DIGESTIVE DISEASES AND SCIENCES

A novel model using mean platelet volume and neutrophil to lymphocyte ratio as a marker of nonalcoholic steatohepatitis in NAFLD patients

(2016) Ahmed Abdel-Razik et al.   EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY

Inflammation in Alcoholic and Nonalcoholic Fatty Liver Disease: Friend or Foe?

(2016) Bin Gao et al.   GASTROENTEROLOGY

Novel plasma biomarkers associated with liver disease severity in adults with nonalcoholic fatty liver disease

(2016) Veeral Ajmera et al.   HEPATOLOGY

Inflammasome-activated gasdermin D causes pyroptosis by forming membrane pores

(2016) Xing Liu et al.   NATURE

Parabolic relationship between sex-specific serum high sensitive C reactive protein and non-alcoholic fatty liver disease in chinese adults: a large population-based study

(2016) Li-Ren Wang et al.   Oncotarget

Interleukin-34 as a fibroblast-derived marker of liver fibrosis in patients with non-alcoholic fatty liver disease

(2016) Hirotaka Shoji et al.   Scientific Reports

Role of NLRP3 Inflammasome in the Progression of NAFLD to NASH

(2016) Xingyong Wan et al.   Canadian Journal of Gastroenterology and Hepatology

The association of nonalcoholic fatty liver disease, obesity, and metabolic syndrome, with systemic inflammation and subclinical atherosclerosis: The Multi-Ethnic Study of Atherosclerosis (MESA)

(2015) Mahmoud Al Rifai et al.   ATHEROSCLEROSIS

Association of Adipose Tissue Inflammation With Histologic Severity of Nonalcoholic Fatty Liver Disease

(2015) Johannie du Plessis et al.   GASTROENTEROLOGY

P1081 : Hyperplastic colonic polyps link to nonalcoholic steatohepatitis and vitamin D deficiency

(2015) M. Mahamid et al.   JOURNAL OF HEPATOLOGY

Inflammasome activation and function in liver disease

(2015) Gyongyi Szabo et al.   Nature Reviews Gastroenterology & Hepatology

Epidemiology and Natural History of Nonalcoholic Fatty Liver Disease

(2015) Sanjaya Satapathy et al.   SEMINARS IN LIVER DISEASE

Increased plasma CgA levels associated with nonalcoholic fatty liver disease

(2015) Peng-Bo Wo et al.   Turkish Journal of Gastroenterology

The development of a clinical score for the prediction of nonalcoholic steatohepatitis in patients with nonalcoholic fatty liver disease using routine parameters

(2015) Li Chunming et al.   Turkish Journal of Gastroenterology

LPS-induced TNF-α factor mediates pro-inflammatory and pro-fibrogenic pattern in non-alcoholic fatty liver disease

(2015) Sara Ceccarelli et al.   Oncotarget

Global publication trends and research hotspots of nonalcoholic fatty liver disease: a bibliometric analysis and systematic review

(2015) Tong-shuo Zhang et al.   SpringerPlus

β-Arrestin 2 Negatively Regulates Toll-like Receptor 4 (TLR4)-triggered Inflammatory Signaling via Targeting p38 MAPK and Interleukin 10

(2014) Hui Li et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Distinct cytokines balance the development of regulatory T cells and interleukin-10-producing regulatory B cells

(2013) Vladimir Holan et al.   IMMUNOLOGY

Accuracy of prediction scores and novel biomarkers for predicting nonalcoholic fatty liver disease in obese children

(2013) Bart G.P. Koot et al.   Obesity

Nonalcoholic fatty liver disease in severely obese adolescent and adult patients

(2013) Ai-Xuan L. Holterman et al.   Obesity

Non-Alcoholic Fatty Liver Disease Is Closely Associated with Sub-Clinical Inflammation: A Case-Control Study on Asian Indians in North India

(2013) Priyanka Nigam et al.   PLoS One

Soluble CD14 Levels Reflect Liver Inflammation in Patients with Nonalcoholic Steatohepatitis

(2013) Yuji Ogawa et al.   PLoS One

Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity

(2012) Jorge Henao-Mejia et al.   NATURE

Decreased Circulating Endothelial Progenitor Cell Levels and Function in Patients with Nonalcoholic Fatty Liver Disease

(2012) Chia-Hung Chiang et al.   PLoS One

Serum sex hormone-binding globulin levels are independently associated with nonalcoholic fatty liver disease in people with type 2 diabetes

(2011) Jang Yel Shin et al.   DIABETES RESEARCH AND CLINICAL PRACTICE

Inflammatory Markers in Relation to Nonalcoholic Fatty Liver Disease in Urban South Indians

(2011) Gokulakrishnan Kuppan et al.   Diabetes Technology & Therapeutics

Serum Cytokeratin 18 M30 Antigen Level and Its Correlation with Nutritional Parameters in Middle-Aged Japanese Males with Nonalcoholic Fatty Liver Disease (NAFLD)

(2011) Mayumi TABUCHI et al.   JOURNAL OF NUTRITIONAL SCIENCE AND VITAMINOLOGY

Enhanced expression of pro-inflammatory mediators and liver X-receptor-regulated lipogenic genes in non-alcoholic fatty liver disease and hepatitis C

(2010) Elena Lima-Cabello et al.   CLINICAL SCIENCE

Endotoxin and Plasminogen Activator Inhibitor-1 Serum Levels Associated With Nonalcoholic Steatohepatitis in Children

(2010) Anna Alisi et al.   JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION

Non-alcoholic fatty liver disease and its association with obesity, insulin resistance and increased serum levels of C-reactive protein in Hispanics

(2010) Arnoldo Riquelme et al.   LIVER INTERNATIONAL

The Relation Between Non-Alcoholic Fatty Liver Disease and the Risk of Coronary Heart Disease in Koreans

(2009) Su-Yeon Choi et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

High-sensitivity C-reactive protein as a serum predictor of nonalcoholic fatty liver disease based on the Akaike Information Criterion scoring system in the general Japanese population

(2009) Tomomi Kogiso et al.   JOURNAL OF GASTROENTEROLOGY

Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement

(2009) David Moher et al.   PLOS MEDICINE

The severity of nonalcoholic fatty liver disease is associated with increased cardiovascular risk in a large cohort of non-obese Asian subjects

(2008) Ki Chul Sung et al.   ATHEROSCLEROSIS

Serum Adipocyte Fatty Acid-Binding Protein Levels Are Associated With Nonalcoholic Fatty Liver Disease in Type 2 Diabetic Patients

(2008) J. Hyun Koh et al.   DIABETES CARE